Interaction between Cryptococcus neoformans and alveolar macrophages

Journal of Medical and Veterinary Mycology

Volumn 35, Issue 4, 1997, Pages 263-269

  Gross, N T ^a,b,c   Nessa, K ^a,b   Camner, P ^b   Chinchilla, M ^c   Jarstrand, C ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

Alveolar macrophages; Cryptococcus neoformans; Oxidative metabolism; Phagocytosis; Phagolysosomal pH

Indexed keywords

AEROBIC METABOLISM; ANIMAL CELL; ARTICLE; CELL PH; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; LUNG ALVEOLUS MACROPHAGE; LYSOSOME; MALE; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PHAGOCYTOSIS; RAT;

ANIMALIA; FILOBASIDIELLA NEOFORMANS;

EID: 80051508800     PISSN: 02681218     EISSN: None     Source Type: Journal    
DOI: 10.1080/02681219780001251     Document Type: Article

References (29)

1. Dupont B, Graybill JR, Armstrong D, et al. Fungal infections in AIDs patients. J Med Vet Mycol 1992; 30 (Suppl. 1): 19-28.
2. Perfect JR, Durack DT, Gallis HA. Cryptococcemia. Medicine 1983; 62: 98-109.
3. White MH, Armstrong D. Cryptococcosis. Infect Dis Clin North Am 1994; 8: 383-98.
4. Hocking WG, Golde DW. The pulmonary-alveola marcophage. N Engl J Med 1979; 301: 580-7.
5. Bolanos B, Mitchell TG. Phagocytosis of Cryptococcus neoformans by rat alveolar macrophages. J Med Vet Mycol 1989; 27: 203-17.
6. Bolaños B, Mitchell TG. Phagocytosis and killing of Cryptococcus neoformans by rat alevolar macrophages in the absence of serum. J Leukoc Biol 1989; 46: 521-8.
7. Flesch IEA, Schwamberger G, Kaufmann SHE. Fungicidal activity of INF-gamma-activated macrophages. Extracellular killing of Cryptococcus neoformans. J Immunol 1989; 142: 3219-24.
8. Levitz SM, DiBenedetto DJ. Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans. J Immunol 1989; 142: 659-65.
9. Nyberg K, Nessa K, Johansson A, et al. Alveolar macrophage response to yeasts and inert particles. J Med Vet Mycol 1996; 34: 11-17.
10. Wiernik A, Johansson A, Jarstrand C, Camner P. Rabbit lung after inhalation of soluble nickel. I. Effects on alveolar macrophages. Environ Res 1983; 30: 129-41.
11. Hed J. The extinction of fluorescence by crystal violet and its use to differentiate between attached and ingested microorganisms in phagocytosis. FEMS Microbiol Lett 1977; 1: 357-61.
12. Jarstrand C, Lundborg M, Wernik A, Camner P. Alveolar macrophage function in nickel dust exposed rabbits. Toxicology 1978; 11: 353-9.
13. Nyberg K, Johansson U, Rundquist I, Camner P. Estimation of pH in individual alveolar macrophage phagolysosomes. Exp Lung Res 1989; 15: 499-510.
14. Ohkuma S, Poole B. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc Natl Acad Sci USA 1978; 75: 3327-31.
15. Goldman D, Lee SC, Casadevall A. Pathogenesis of pulmonary Crvptoeoccus neoformans infection in the rat. Infect Immun 1994; 62: 4655-761.
16. Bulmer GS, Tacker JR. Phagocytosis of Crvptoeoccus neoformans by alveolar macrophages. Infect Immun 1975; 11: 73-9.
17. Kozel TR, Gotschlich EC. The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J Immunol 1982; 129: 1675-80.
18. Levitz SM, Macrophage-Cryptococcus interactions. Immunol Ser 1994; 60: 533-43.
19. Kozel TR. Opsonization and phagocytosis of Cryptococcus neoformans. Arch Med Res 1993; 24: 211-18.
20. Levitz SM, Tabuni A, Wagner R, et al. Binding of unopsonized Cryptoeoccus neoformans by human bronchoalveolar macrophages: inhibition by a large molecular size serum component. J Infect Dis 1992; 166: 866-73.
21. Weinberg PB, Backer S, Granger DL, Koren HS. Growth inhibition of Cryptocoecus neoformans by human alveolar macrophages. Am Rev Respir Dis 1987; 136: 1242-7.
22. Vecchiarelli A, Dottorini M, Pietrella D, et al. Role of human alveolar macrophages as antigen-presenting cells in Cryptocoecus neoformans infection. Am J Respir Cell Mol Biol 1994; 11: 130-7.
23. Reynolds HY, Newball HH. Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J Lab Clin Med 1974; 84: 559-73.
24. Robertson J, Caldwell JR, Castle JR, Waldman RH. Evidence for the presence of components of the alternative (properdin) pathway of complement activation in respiratory secretions. J Immunol 1976; 117: 900-3.
25. Chakravarti B, Chakravarti DM. Phagocytosis: an overview. Pathol Immunopathol Res 1987; 6: 316-42.
26. Wright SD, Silverstein SC. Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes. J Exp Med 1983; 158: 2016-23.
27. Herting E, Jarstrand C, Rasool O, et al. Effect of surfactant on nitroblue tetrazolium reduction of polymorphonuclear leucocytes stimulated with type la group B streptococci. Acta Paediatr 1995; 84: 922-6.
28. Hidalgo HA, Helmke RJ, German VF, Mangos JA. Pneumocystis carinii induces an oxidative burst in alveolar macrophages. Infect Immun 1992; 60: 1-7.
29. Kagaya K, Yamada T, Miyakawa Y, et al. Characterization of pathogenic constituents of Cryptocoecus neoformans strains. Microbiol Immunol 1985; 29: 517-32.